nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—ADRB2—polycystic ovary syndrome	0.339	1	CbGaD
Desipramine—SLC22A3—Metformin—polycystic ovary syndrome	0.186	0.475	CbGbCtD
Desipramine—SLC22A2—Metformin—polycystic ovary syndrome	0.11	0.281	CbGbCtD
Desipramine—SLC22A1—Metformin—polycystic ovary syndrome	0.0957	0.244	CbGbCtD
Desipramine—SMPD1—urine—polycystic ovary syndrome	0.00837	0.12	CbGeAlD
Desipramine—CYP2C19—urine—polycystic ovary syndrome	0.00289	0.0413	CbGeAlD
Desipramine—CYP1A2—urine—polycystic ovary syndrome	0.00236	0.0338	CbGeAlD
Desipramine—CYP2E1—urine—polycystic ovary syndrome	0.00213	0.0304	CbGeAlD
Desipramine—HTR2A—urine—polycystic ovary syndrome	0.00185	0.0264	CbGeAlD
Desipramine—SMPD1—adipose tissue—polycystic ovary syndrome	0.00178	0.0255	CbGeAlD
Desipramine—CYP3A4—urine—polycystic ovary syndrome	0.00171	0.0244	CbGeAlD
Desipramine—CYP2D6—urine—polycystic ovary syndrome	0.00168	0.024	CbGeAlD
Desipramine—SMPD1—adrenal gland—polycystic ovary syndrome	0.0016	0.0229	CbGeAlD
Desipramine—SMPD1—female gonad—polycystic ovary syndrome	0.00149	0.0213	CbGeAlD
Desipramine—SMPD1—vagina—polycystic ovary syndrome	0.00148	0.0212	CbGeAlD
Desipramine—SMPD1—endocrine gland—polycystic ovary syndrome	0.00139	0.0198	CbGeAlD
Desipramine—CYP2C18—vagina—polycystic ovary syndrome	0.00121	0.0172	CbGeAlD
Desipramine—SLC22A3—embryo—polycystic ovary syndrome	0.00116	0.0166	CbGeAlD
Desipramine—CYP2C18—endocrine gland—polycystic ovary syndrome	0.00113	0.0161	CbGeAlD
Desipramine—ORM1—endometrium—polycystic ovary syndrome	0.00097	0.0138	CbGeAlD
Desipramine—CYP2A6—adipose tissue—polycystic ovary syndrome	0.000959	0.0137	CbGeAlD
Desipramine—SLC22A4—endometrium—polycystic ovary syndrome	0.000933	0.0133	CbGeAlD
Desipramine—SLC22A3—endometrium—polycystic ovary syndrome	0.000849	0.0121	CbGeAlD
Desipramine—SLC22A4—pituitary gland—polycystic ovary syndrome	0.000844	0.0121	CbGeAlD
Desipramine—SLC22A4—adipose tissue—polycystic ovary syndrome	0.000841	0.012	CbGeAlD
Desipramine—SLC22A1—adipose tissue—polycystic ovary syndrome	0.000801	0.0114	CbGeAlD
Desipramine—CYP2A6—vagina—polycystic ovary syndrome	0.000798	0.0114	CbGeAlD
Desipramine—ADRB1—adipose tissue—polycystic ovary syndrome	0.000771	0.011	CbGeAlD
Desipramine—SLC22A3—adipose tissue—polycystic ovary syndrome	0.000765	0.0109	CbGeAlD
Desipramine—SLC22A4—adrenal gland—polycystic ovary syndrome	0.000754	0.0108	CbGeAlD
Desipramine—SLC22A4—vagina—polycystic ovary syndrome	0.000699	0.00998	CbGeAlD
Desipramine—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.000691	0.00987	CbGeAlD
Desipramine—SLC22A3—adrenal gland—polycystic ovary syndrome	0.000686	0.0098	CbGeAlD
Desipramine—ORM1—endocrine gland—polycystic ovary syndrome	0.00068	0.00971	CbGeAlD
Desipramine—SLC22A1—vagina—polycystic ovary syndrome	0.000666	0.0095	CbGeAlD
Desipramine—CHRM3—adipose tissue—polycystic ovary syndrome	0.000664	0.00948	CbGeAlD
Desipramine—SLC22A3—female gonad—polycystic ovary syndrome	0.00064	0.00914	CbGeAlD
Desipramine—SLC22A3—vagina—polycystic ovary syndrome	0.000636	0.00908	CbGeAlD
Desipramine—CHRM2—endocrine gland—polycystic ovary syndrome	0.000634	0.00905	CbGeAlD
Desipramine—SLC22A1—endocrine gland—polycystic ovary syndrome	0.000623	0.00889	CbGeAlD
Desipramine—SLC22A5—endometrium—polycystic ovary syndrome	0.000617	0.00882	CbGeAlD
Desipramine—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.0006	0.00857	CbGeAlD
Desipramine—DRD2—pituitary gland—polycystic ovary syndrome	0.0006	0.00857	CbGeAlD
Desipramine—ADRB1—endocrine gland—polycystic ovary syndrome	0.0006	0.00856	CbGeAlD
Desipramine—HTR2A—embryo—polycystic ovary syndrome	0.000598	0.00853	CbGeAlD
Desipramine—SLC22A3—endocrine gland—polycystic ovary syndrome	0.000595	0.0085	CbGeAlD
Desipramine—HTR1A—adrenal gland—polycystic ovary syndrome	0.000593	0.00847	CbGeAlD
Desipramine—SLC6A2—adrenal gland—polycystic ovary syndrome	0.000588	0.0084	CbGeAlD
Desipramine—SLC6A4—endocrine gland—polycystic ovary syndrome	0.000579	0.00827	CbGeAlD
Desipramine—CHRM1—endocrine gland—polycystic ovary syndrome	0.000577	0.00824	CbGeAlD
Desipramine—SLC22A5—pituitary gland—polycystic ovary syndrome	0.000559	0.00798	CbGeAlD
Desipramine—SLC22A5—adipose tissue—polycystic ovary syndrome	0.000556	0.00795	CbGeAlD
Desipramine—CHRM3—female gonad—polycystic ovary syndrome	0.000555	0.00793	CbGeAlD
Desipramine—HRH1—endometrium—polycystic ovary syndrome	0.000524	0.00748	CbGeAlD
Desipramine—CHRM3—endocrine gland—polycystic ovary syndrome	0.000516	0.00737	CbGeAlD
Desipramine—HTR1A—endocrine gland—polycystic ovary syndrome	0.000514	0.00735	CbGeAlD
Desipramine—CYP2C19—vagina—polycystic ovary syndrome	0.000513	0.00733	CbGeAlD
Desipramine—SLC6A2—endocrine gland—polycystic ovary syndrome	0.00051	0.00728	CbGeAlD
Desipramine—SLC22A5—adrenal gland—polycystic ovary syndrome	0.000499	0.00713	CbGeAlD
Desipramine—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00048	0.00685	CbGeAlD
Desipramine—HRH1—adipose tissue—polycystic ovary syndrome	0.000472	0.00674	CbGeAlD
Desipramine—Acepromazine—ADRA1B—polycystic ovary syndrome	0.000472	0.0642	CrCbGaD
Desipramine—Benazepril—MTHFR—polycystic ovary syndrome	0.00047	0.064	CrCbGaD
Desipramine—SLC22A5—female gonad—polycystic ovary syndrome	0.000465	0.00665	CbGeAlD
Desipramine—DRD2—endocrine gland—polycystic ovary syndrome	0.000465	0.00664	CbGeAlD
Desipramine—SLC22A5—vagina—polycystic ovary syndrome	0.000462	0.00661	CbGeAlD
Desipramine—Epinastine—ADRA1A—polycystic ovary syndrome	0.000456	0.0621	CrCbGaD
Desipramine—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000433	0.00619	CbGeAlD
Desipramine—HRH1—adrenal gland—polycystic ovary syndrome	0.000423	0.00604	CbGeAlD
Desipramine—Nortriptyline—ADRA1D—polycystic ovary syndrome	0.000411	0.0559	CrCbGaD
Desipramine—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000407	0.00581	CbGeAlD
Desipramine—CYP2B6—vagina—polycystic ovary syndrome	0.000402	0.00574	CbGeAlD
Desipramine—HTR2A—pituitary gland—polycystic ovary syndrome	0.000396	0.00565	CbGeAlD
Desipramine—HRH1—female gonad—polycystic ovary syndrome	0.000395	0.00564	CbGeAlD
Desipramine—HRH1—vagina—polycystic ovary syndrome	0.000392	0.0056	CbGeAlD
Desipramine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000392	0.0056	CbGeAlD
Desipramine—ABCB1—embryo—polycystic ovary syndrome	0.000392	0.00559	CbGeAlD
Desipramine—Benazepril—ACE—polycystic ovary syndrome	0.000383	0.0521	CrCbGaD
Desipramine—CYP2B6—endocrine gland—polycystic ovary syndrome	0.000376	0.00537	CbGeAlD
Desipramine—Doxepin—ADRA1D—polycystic ovary syndrome	0.000368	0.0501	CrCbGaD
Desipramine—HRH1—endocrine gland—polycystic ovary syndrome	0.000367	0.00524	CbGeAlD
Desipramine—HTR2A—adrenal gland—polycystic ovary syndrome	0.000353	0.00505	CbGeAlD
Desipramine—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000353	0.00504	CbGeAlD
Desipramine—Nortriptyline—ADRA1B—polycystic ovary syndrome	0.00035	0.0477	CrCbGaD
Desipramine—Trimipramine—ADRA1B—polycystic ovary syndrome	0.00033	0.0449	CrCbGaD
Desipramine—HTR2A—vagina—polycystic ovary syndrome	0.000328	0.00468	CbGeAlD
Desipramine—Promazine—ADRA1D—polycystic ovary syndrome	0.000327	0.0446	CrCbGaD
Desipramine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000321	0.00458	CbGeAlD
Desipramine—Acepromazine—ADRA1A—polycystic ovary syndrome	0.000317	0.0432	CrCbGaD
Desipramine—Doxepin—ADRA1B—polycystic ovary syndrome	0.000314	0.0428	CrCbGaD
Desipramine—HTR2A—endocrine gland—polycystic ovary syndrome	0.000307	0.00438	CbGeAlD
Desipramine—CYP2D6—female gonad—polycystic ovary syndrome	0.0003	0.00429	CbGeAlD
Desipramine—Imipramine—ADRA1D—polycystic ovary syndrome	0.000287	0.039	CrCbGaD
Desipramine—ABCB1—endometrium—polycystic ovary syndrome	0.000287	0.00409	CbGeAlD
Desipramine—Amitriptyline—ADRA1D—polycystic ovary syndrome	0.000285	0.0388	CrCbGaD
Desipramine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000284	0.00405	CbGeAlD
Desipramine—Promazine—ADRA1B—polycystic ovary syndrome	0.000279	0.038	CrCbGaD
Desipramine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000279	0.00399	CbGeAlD
Desipramine—ABCB1—uterus—polycystic ovary syndrome	0.000264	0.00377	CbGeAlD
Desipramine—ABCB1—pituitary gland—polycystic ovary syndrome	0.000259	0.0037	CbGeAlD
Desipramine—ABCB1—adipose tissue—polycystic ovary syndrome	0.000258	0.00369	CbGeAlD
Desipramine—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.000246	0.0335	CrCbGaD
Desipramine—Imipramine—ADRA1B—polycystic ovary syndrome	0.000245	0.0333	CrCbGaD
Desipramine—Amitriptyline—ADRA1B—polycystic ovary syndrome	0.000243	0.0331	CrCbGaD
Desipramine—Nortriptyline—ADRA1A—polycystic ovary syndrome	0.000236	0.0321	CrCbGaD
Desipramine—ABCB1—adrenal gland—polycystic ovary syndrome	0.000232	0.00331	CbGeAlD
Desipramine—Trimipramine—ADRA1A—polycystic ovary syndrome	0.000222	0.0302	CrCbGaD
Desipramine—ABCB1—female gonad—polycystic ovary syndrome	0.000216	0.00308	CbGeAlD
Desipramine—ABCB1—vagina—polycystic ovary syndrome	0.000215	0.00307	CbGeAlD
Desipramine—Promethazine—ADRA1A—polycystic ovary syndrome	0.000214	0.0291	CrCbGaD
Desipramine—Doxepin—ADRA1A—polycystic ovary syndrome	0.000212	0.0288	CrCbGaD
Desipramine—ABCB1—endocrine gland—polycystic ovary syndrome	0.000201	0.00287	CbGeAlD
Desipramine—Promazine—ADRA1A—polycystic ovary syndrome	0.000188	0.0256	CrCbGaD
Desipramine—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.000166	0.0225	CrCbGaD
Desipramine—Imipramine—ADRA1A—polycystic ovary syndrome	0.000165	0.0224	CrCbGaD
Desipramine—Amitriptyline—ADRA1A—polycystic ovary syndrome	0.000164	0.0223	CrCbGaD
Desipramine—Lightheadedness—Metformin—polycystic ovary syndrome	8.93e-05	0.0661	CcSEcCtD
Desipramine—Liver function test abnormal—Metformin—polycystic ovary syndrome	6.69e-05	0.0495	CcSEcCtD
Desipramine—Drowsiness—Metformin—polycystic ovary syndrome	5.58e-05	0.0413	CcSEcCtD
Desipramine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	5.47e-05	0.0405	CcSEcCtD
Desipramine—Hepatitis—Metformin—polycystic ovary syndrome	5.01e-05	0.0371	CcSEcCtD
Desipramine—Hypoaesthesia—Metformin—polycystic ovary syndrome	4.99e-05	0.0369	CcSEcCtD
Desipramine—Flushing—Metformin—polycystic ovary syndrome	4.65e-05	0.0344	CcSEcCtD
Desipramine—Dysgeusia—Metformin—polycystic ovary syndrome	4.27e-05	0.0316	CcSEcCtD
Desipramine—Vision blurred—Metformin—polycystic ovary syndrome	4.11e-05	0.0304	CcSEcCtD
Desipramine—Tremor—Metformin—polycystic ovary syndrome	4.09e-05	0.0303	CcSEcCtD
Desipramine—Ill-defined disorder—Metformin—polycystic ovary syndrome	4.05e-05	0.03	CcSEcCtD
Desipramine—Malaise—Metformin—polycystic ovary syndrome	3.94e-05	0.0291	CcSEcCtD
Desipramine—Palpitations—Metformin—polycystic ovary syndrome	3.86e-05	0.0285	CcSEcCtD
Desipramine—Hypertension—Metformin—polycystic ovary syndrome	3.77e-05	0.0279	CcSEcCtD
Desipramine—Discomfort—Metformin—polycystic ovary syndrome	3.67e-05	0.0272	CcSEcCtD
Desipramine—Oedema—Metformin—polycystic ovary syndrome	3.56e-05	0.0264	CcSEcCtD
Desipramine—Thrombocytopenia—Metformin—polycystic ovary syndrome	3.49e-05	0.0258	CcSEcCtD
Desipramine—Anorexia—Metformin—polycystic ovary syndrome	3.4e-05	0.0251	CcSEcCtD
Desipramine—Hypotension—Metformin—polycystic ovary syndrome	3.33e-05	0.0246	CcSEcCtD
Desipramine—Paraesthesia—Metformin—polycystic ovary syndrome	3.2e-05	0.0237	CcSEcCtD
Desipramine—Somnolence—Metformin—polycystic ovary syndrome	3.17e-05	0.0234	CcSEcCtD
Desipramine—Dyspepsia—Metformin—polycystic ovary syndrome	3.14e-05	0.0232	CcSEcCtD
Desipramine—Decreased appetite—Metformin—polycystic ovary syndrome	3.1e-05	0.0229	CcSEcCtD
Desipramine—Fatigue—Metformin—polycystic ovary syndrome	3.07e-05	0.0227	CcSEcCtD
Desipramine—Constipation—Metformin—polycystic ovary syndrome	3.05e-05	0.0225	CcSEcCtD
Desipramine—Feeling abnormal—Metformin—polycystic ovary syndrome	2.94e-05	0.0217	CcSEcCtD
Desipramine—Urticaria—Metformin—polycystic ovary syndrome	2.83e-05	0.0209	CcSEcCtD
Desipramine—Abdominal pain—Metformin—polycystic ovary syndrome	2.82e-05	0.0208	CcSEcCtD
Desipramine—Asthenia—Metformin—polycystic ovary syndrome	2.56e-05	0.0189	CcSEcCtD
Desipramine—Pruritus—Metformin—polycystic ovary syndrome	2.52e-05	0.0186	CcSEcCtD
Desipramine—Diarrhoea—Metformin—polycystic ovary syndrome	2.44e-05	0.018	CcSEcCtD
Desipramine—Dizziness—Metformin—polycystic ovary syndrome	2.36e-05	0.0174	CcSEcCtD
Desipramine—Vomiting—Metformin—polycystic ovary syndrome	2.26e-05	0.0168	CcSEcCtD
Desipramine—Rash—Metformin—polycystic ovary syndrome	2.25e-05	0.0166	CcSEcCtD
Desipramine—Dermatitis—Metformin—polycystic ovary syndrome	2.24e-05	0.0166	CcSEcCtD
Desipramine—Headache—Metformin—polycystic ovary syndrome	2.23e-05	0.0165	CcSEcCtD
Desipramine—Nausea—Metformin—polycystic ovary syndrome	2.12e-05	0.0157	CcSEcCtD
Desipramine—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.41e-06	3.37e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	6.39e-06	3.35e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	6.38e-06	3.35e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.35e-06	3.33e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	6.31e-06	3.31e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	6.19e-06	3.25e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IRS1—polycystic ovary syndrome	6.19e-06	3.25e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	6.12e-06	3.21e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	6.12e-06	3.21e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	6.1e-06	3.2e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	6.02e-06	3.16e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	6.02e-06	3.16e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	6e-06	3.15e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	6e-06	3.15e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	5.99e-06	3.14e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	5.99e-06	3.14e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	5.99e-06	3.14e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	5.97e-06	3.13e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—POMC—polycystic ovary syndrome	5.96e-06	3.13e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	5.95e-06	3.12e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—INS—polycystic ovary syndrome	5.92e-06	3.11e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	5.92e-06	3.11e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	5.89e-06	3.09e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	5.83e-06	3.06e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	5.81e-06	3.05e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.81e-06	3.05e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	5.78e-06	3.03e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IGF1—polycystic ovary syndrome	5.73e-06	3.01e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT2—polycystic ovary syndrome	5.73e-06	3e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.71e-06	3e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	5.71e-06	3e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—POMC—polycystic ovary syndrome	5.71e-06	2.99e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.7e-06	2.99e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	5.7e-06	2.99e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	5.69e-06	2.99e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	5.69e-06	2.98e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.68e-06	2.98e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—INS—polycystic ovary syndrome	5.67e-06	2.98e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.67e-06	2.97e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—TH—polycystic ovary syndrome	5.66e-06	2.97e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	5.64e-06	2.96e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.61e-06	2.94e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	5.61e-06	2.94e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	5.6e-06	2.94e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	5.58e-06	2.93e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	5.57e-06	2.92e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	5.56e-06	2.92e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	5.56e-06	2.92e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	5.56e-06	2.92e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	5.56e-06	2.91e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	5.53e-06	2.9e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—INS—polycystic ovary syndrome	5.53e-06	2.9e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—TH—polycystic ovary syndrome	5.53e-06	2.9e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	5.53e-06	2.9e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.52e-06	2.9e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	5.51e-06	2.89e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	5.51e-06	2.89e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	5.49e-06	2.88e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	5.49e-06	2.88e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	5.49e-06	2.88e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	5.48e-06	2.88e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.45e-06	2.86e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.44e-06	2.86e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	5.44e-06	2.86e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	5.41e-06	2.84e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	5.41e-06	2.84e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	5.38e-06	2.82e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	5.36e-06	2.81e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	5.26e-06	2.76e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.21e-06	2.73e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	5.21e-06	2.73e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	5.19e-06	2.73e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	5.18e-06	2.72e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	5.18e-06	2.72e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	5.18e-06	2.72e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	5.18e-06	2.72e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	5.16e-06	2.71e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	5.15e-06	2.7e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	5.11e-06	2.68e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	5.1e-06	2.68e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—INS—polycystic ovary syndrome	5.08e-06	2.66e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.08e-06	2.66e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	5.07e-06	2.66e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	5.06e-06	2.65e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	5.05e-06	2.65e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	4.96e-06	2.6e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	4.89e-06	2.56e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	4.88e-06	2.56e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	4.86e-06	2.55e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	4.86e-06	2.55e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	4.85e-06	2.55e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	4.83e-06	2.53e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	4.8e-06	2.52e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	4.79e-06	2.52e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	4.79e-06	2.51e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	4.78e-06	2.51e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.78e-06	2.51e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	4.78e-06	2.51e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	4.78e-06	2.51e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	4.76e-06	2.5e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	4.76e-06	2.5e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—INS—polycystic ovary syndrome	4.76e-06	2.5e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	4.75e-06	2.49e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	4.72e-06	2.47e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	4.7e-06	2.47e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.7e-06	2.47e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.7e-06	2.46e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	4.69e-06	2.46e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	4.68e-06	2.45e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	4.67e-06	2.45e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	4.66e-06	2.45e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	4.65e-06	2.44e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	4.65e-06	2.44e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.63e-06	2.43e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	4.63e-06	2.43e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	4.62e-06	2.43e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	4.62e-06	2.42e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	4.6e-06	2.41e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	4.6e-06	2.41e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	4.51e-06	2.37e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	4.5e-06	2.36e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	4.49e-06	2.36e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	4.47e-06	2.35e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	4.47e-06	2.35e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.46e-06	2.34e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4.46e-06	2.34e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	4.41e-06	2.32e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	4.4e-06	2.31e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	4.38e-06	2.3e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.37e-06	2.29e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	4.3e-06	2.26e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	4.29e-06	2.25e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.29e-06	2.25e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.27e-06	2.24e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	4.26e-06	2.24e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	4.25e-06	2.23e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.25e-06	2.23e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.23e-06	2.22e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	4.2e-06	2.2e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	4.19e-06	2.2e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.18e-06	2.2e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	4.18e-06	2.19e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	4.18e-06	2.19e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.17e-06	2.19e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	4.16e-06	2.18e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	4.12e-06	2.16e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	4.12e-06	2.16e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	4.1e-06	2.15e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—INS—polycystic ovary syndrome	4.1e-06	2.15e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	4.09e-06	2.15e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	4.08e-06	2.14e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	4.08e-06	2.14e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	4.05e-06	2.13e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	4.04e-06	2.12e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	4.04e-06	2.12e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	4.04e-06	2.12e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	4.03e-06	2.11e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	4.02e-06	2.11e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	4.02e-06	2.11e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—INS—polycystic ovary syndrome	4.01e-06	2.11e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	4.01e-06	2.1e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	4e-06	2.1e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4e-06	2.1e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	3.99e-06	2.1e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	3.98e-06	2.09e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	3.97e-06	2.08e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	3.95e-06	2.07e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	3.95e-06	2.07e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	3.94e-06	2.07e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.94e-06	2.07e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	3.89e-06	2.04e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	3.88e-06	2.04e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	3.88e-06	2.04e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.88e-06	2.03e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.87e-06	2.03e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.86e-06	2.03e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.86e-06	2.03e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	3.85e-06	2.02e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	3.85e-06	2.02e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	3.84e-06	2.02e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	3.81e-06	2e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	3.81e-06	2e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	3.8e-06	1.99e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.75e-06	1.97e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.74e-06	1.96e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.69e-06	1.94e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.68e-06	1.93e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.67e-06	1.93e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.66e-06	1.92e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.62e-06	1.9e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	3.6e-06	1.89e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.6e-06	1.89e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.58e-06	1.88e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	3.58e-06	1.88e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	3.52e-06	1.85e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	3.44e-06	1.8e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	3.43e-06	1.8e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	3.42e-06	1.8e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.41e-06	1.79e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.31e-06	1.74e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.25e-06	1.71e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	3.16e-06	1.66e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.12e-06	1.63e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	3.11e-06	1.63e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	3.1e-06	1.62e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	3.08e-06	1.62e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.07e-06	1.61e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	3.04e-06	1.59e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	3.03e-06	1.59e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—INS—polycystic ovary syndrome	3.02e-06	1.59e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	3.02e-06	1.58e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3e-06	1.58e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.97e-06	1.56e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.96e-06	1.56e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.95e-06	1.55e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	2.95e-06	1.55e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.94e-06	1.54e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.92e-06	1.53e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	2.92e-06	1.53e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.9e-06	1.52e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.86e-06	1.5e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.85e-06	1.49e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.78e-06	1.46e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.65e-06	1.39e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	2.59e-06	1.36e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.58e-06	1.35e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.54e-06	1.33e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.53e-06	1.33e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.52e-06	1.32e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.52e-06	1.32e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.51e-06	1.32e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.49e-06	1.31e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	2.48e-06	1.3e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	2.46e-06	1.29e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	2.43e-06	1.27e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	2.41e-06	1.27e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.34e-06	1.23e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	2.12e-06	1.11e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	2.08e-06	1.09e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.03e-06	1.07e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	2.02e-06	1.06e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.9e-06	9.96e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.87e-06	9.82e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.86e-06	9.77e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	1.78e-06	9.36e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.75e-06	9.21e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	1.75e-06	9.19e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	1.75e-06	9.16e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	1.74e-06	9.13e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	1.72e-06	9.04e-06	CbGpPWpGaD
